As the master epigenetic regulator, EZH2 controls gene silencing through its mark H3K27me3 and it can alter the metabolic profile of tumor cells through the metabolism of glucose, lipids and amino acids, as demonstrated in recent studies [118]. This evidence concerns the gene EZH2 and neoplasm.